日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CEBPB Expression in Tumor Cells Drives Immune Evasion in Colorectal Cancer via CTLA4 Up-regulation in T Cells.

肿瘤细胞中 CEBPB 的表达通过 T 细胞中 CTLA4 的上调驱动结直肠癌的免疫逃逸。

Yun Hye Jeong, Park Chan Ho, Yun Dahye, Shin Hye-Ri, Lee Jeong Dong, Park Changhee, Kim Kiyeon, Shim Heejun, Sim Hyejin, Kim Se Min, Kim Min Jung, Park Ji Won, Ryoo Seung-Bum, Lim Yoojoo, Jeong Seung-Yong, Park Kyu Joo, Kim Tae-You, Kim Junil, Won Jae-Kyung, Han Sae-Won

A Randomized Phase II Study: CRS207/GVAX plus Anti-PD-1 and Anti-CTLA4 Recruits Mesothelin- and mKRAS-Specific T Cells into PDAC.

一项随机 II 期研究:CRS207/GVAX 联合抗 PD-1 和抗 CTLA4 可将间皮素和 mKRAS 特异性 T 细胞募集到 PDAC 中。

Bever Katherine M, Huff Amanda L, Danilova Ludmila, Wetzel Meredith, Tandurella Joseph A, Durham Jennifer N, Wang Tingchang, Lee Jae W, Coyne Erin M, Montagne Janelle M, Mitchell Jacob T, Hernandez Alexei G, Shin Sarah M, Anders Robert A, Wang Hao, Fertig Elana J, Jaffee Elizabeth M, Le Dung T, Ho Won Jin

Portrayed the development of activated T cell to exhausted T cell based on the ratio of CD28 to CTLA4

根据 CD28 与 CTLA4 的比值,描绘了活化 T 细胞向耗竭 T 细胞的发育过程。

Wang, Yuan; Mei, Xinyue; Zhong, Jiaying; Wang, Junxiang; Cao, Jinpeng; Zheng, Shaojiang; Qi, Defeng; Wang, Zhongfang

Evaluation of +49 A>G (rs231775) Variant in CTLA4 Gene and SCTLA-4 Serum Levels in Plaque Psoriasis in a Mestizo Mexican Population

对墨西哥混血人群斑块状银屑病中 CTLA4 基因 +49 A>G (rs231775) 变异和 SCTLA-4 血清水平的评估

Cortés-Ruiz, María Guadalupe; Wheber-Hidalgo, Katia Alejandra; Hernández-Nicols, Brenda Fernanda; Buenrostro-Camacho, Fernando Gabriel; Hernández-Bello, Jorge; Graciano-Machuca, Omar; Alvarado-Navarro, Anabell

Disease Stage-Dependent Clinical Impact of CTLA4 Polymorphism in Multiple Myeloma Treated with Autologous Stem Cell Transplantation

CTLA4多态性在自体干细胞移植治疗多发性骨髓瘤中的疾病阶段依赖性临床影响

Horum, Pinar; Seipel, Katja; Shaforostova, Inna; Bertschinger, Martina; Bacher, Ulrike; Pabst, Thomas

Targeted recruitment of USP15 enhances CTLA4 surface levels and restricts its degradation

靶向募集 USP15 可提高 CTLA4 的表面水平并抑制其降解。

Francesca Querques,Victoria Ciampani,Pei Yee Tey,Victoria D Kutilek,Elma Kadic,Michael J Clague,Sylvie Urbé

Efficacy and safety of KN026, a bispecific anti-HER2 antibody, in combination with KN046, an anti-CTLA4/PD-L1 antibody, in patients with advanced HER2-positive nonbreast cancer: a combined analysis of a phase Ib and a phase II study

KN026(一种双特异性抗HER2抗体)联合KN046(一种抗CTLA4/PD-L1抗体)治疗晚期HER2阳性非乳腺癌患者的疗效和安全性:一项Ib期和II期研究的联合分析

Liu, Dan; Gong, Jifang; Li, Jian; Qi, Changsong; Niu, Zuoxing; Liu, Bo; Peng, Zhi; Luo, Suxia; Wang, Xicheng; Wang, Yakun; Zhao, Rusen; Chen, Lilin; Deng, Ting; Li, Zhen; Chen, Lei; Fang, Meimei; Yang, Hongwei; Lu, Linzhi; Zhang, Yanming; Kang, Fengling; Xu, Ting; Zhang, Xiaotian; Shen, Lin

Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

作者更正:CTLA4阻断可消除KEAP1/STK11相关的PD-(L)1抑制剂耐药性

Skoulidis, Ferdinandos; Araujo, Haniel A; Do, Minh Truong; Qian, Yu; Sun, Xin; Cobo, Ana Galan; Le, John T; Montesion, Meagan; Palmer, Rachael; Jahchan, Nadine; Juan, Joseph M; Min, Chengyin; Yu, Yi; Pan, Xuewen; Arbour, Kathryn C; Vokes, Natalie; Schmidt, Stephanie T; Molkentine, David; Owen, Dwight H; Memmott, Regan; Patil, Pradnya D; Marmarelis, Melina E; Awad, Mark M; Murray, Joseph C; Hellyer, Jessica A; Gainor, Justin F; Dimou, Anastasios; Bestvina, Christine M; Shu, Catherine A; Riess, Jonathan W; Blakely, Collin M; Pecot, Chad V; Mezquita, Laura; Tabbó, Fabrizio; Scheffler, Matthias; Digumarthy, Subba; Mooradian, Meghan J; Sacher, Adrian G; Lau, Sally C M; Saltos, Andreas N; Rotow, Julia; Johnson, Rocio Perez; Liu, Corinne; Stewart, Tyler; Goldberg, Sarah B; Killam, Jonathan; Walther, Zenta; Schalper, Kurt; Davies, Kurtis D; Woodcock, Mark G; Anagnostou, Valsamo; Marrone, Kristen A; Forde, Patrick M; Ricciuti, Biagio; Venkatraman, Deepti; Van Allen, Eliezer M; Cummings, Amy L; Goldman, Jonathan W; Shaish, Hiram; Kier, Melanie; Katz, Sharyn; Aggarwal, Charu; Ni, Ying; Azok, Joseph T; Segal, Jeremy; Ritterhouse, Lauren; Neal, Joel W; Lacroix, Ludovic; Elamin, Yasir Y; Negrao, Marcelo V; Le, Xiuning; Lam, Vincent K; Lewis, Whitney E; Kemp, Haley N; Carter, Brett; Roth, Jack A; Swisher, Stephen; Lee, Richard; Zhou, Teng; Poteete, Alissa; Kong, Yifan; Takehara, Tomohiro; Paula, Alvaro Guimaraes; Parra Cuentas, Edwin R; Behrens, Carmen; Wistuba, Ignacio I; Zhang, Jianjun; Blumenschein, George R; Gay, Carl; Byers, Lauren A; Gibbons, Don L; Tsao, Anne; Lee, J Jack; Bivona, Trever G; Camidge, D Ross; Gray, Jhannelle E; Leighl, Natasha B; Levy, Benjamin; Brahmer, Julie R; Garassino, Marina C; Gandara, David R; Garon, Edward B; Rizvi, Naiyer A; Scagliotti, Giorgio Vittorio; Wolf, Jürgen; Planchard, David; Besse, Benjamin; Herbst, Roy S; Wakelee, Heather A; Pennell, Nathan A; Shaw, Alice T; Jänne, Pasi A; Carbone, David P; Hellmann, Matthew D; Rudin, Charles M; Albacker, Lee; Mann, Helen; Zhu, Zhou; Lai, Zhongwu; Stewart, Ross; Peters, Solange; Johnson, Melissa L; Wong, Kwok K; Huang, Alan; Winslow, Monte M; Rosen, Michael J; Winters, Ian P; Papadimitrakopoulou, Vassiliki A; Cascone, Tina; Jewsbury, Philip; Heymach, John V

Targeting LRBA triggers CTLA4 degradation and antitumor immunity for cancer immunotherapy.

靶向 LRBA 可触发 CTLA4 降解和抗肿瘤免疫,用于癌症免疫疗法。

Ge Xiaolu, Yu Liang, Zhang Lei, Jia Liqing, Meng Mingjing, He Jingquan, Bu Fan, Song Yue, Sun Gaorui, Lv Shiming, Mei Desheng, Yang Yutao, Xu Dakang, Zhang Jingfa, Zhang Shengping, Wang Chuangui, Jia Deshui, Chen Yongping, Gao Yue, He Baokun

Reactivation of CTLA4-expressing T cells accelerates resolution of lung fibrosis in a humanized mouse model

在人源化小鼠模型中,CTLA4表达T细胞的重新激活可加速肺纤维化的消退。

Santosh Yadav ,Muralidharan Anbalagan ,Shamima Khatun ,Devadharshini Prabhakaran ,Yasuka Matsunaga ,Justin Manges ,James B McLachlan ,Joseph A Lasky ,Jay Kolls ,Victor J Thannickal